Showing results (121-130 of 138) with videos related to
Sort By:
Pageof 14
Cancer|April 5, 2014
Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute studyMasakuni Serizawa, Yasuhiro Koh, Hirotsugu Kenmotsu, et al.Cancer Reports (Hoboken, N.J.)|October 30, 2023
Prognostic significance of tumor microenvironment assessed by machine learning algorithm in surgically resected non-small cell lung cancerYukihiro Terada, Mitsuhiro Isaka, Akira Ono, et al.Respiratory Investigation|December 4, 2012
Feasibility of postoperative adjuvant chemotherapy of cisplatin plus vinorelbine for completely resected non-small-cell lung cancer: a retrospective study in JapanHirotsugu Kenmotsu, Yasuhisa Ohde, Takehito Shukuya, et al.Journal of Anesthesia|April 1, 2026
Evaluation of postoperative pain by PainVision® PS-2100, a quantitative analyzer for perception and pain in pulmonary resection: a prospective pilot studyTatsuya Masuda, Hideaki Kojima, Tetsuya Mizuno, et al.Lung Cancer (Amsterdam, Netherlands)|December 17, 2018
Genetic alterations of driver genes as independent prognostic factors for disease-free survival in patients with resected non-small cell lung cancerAkira Ono, Mitsuhiro Isaka, Masakuni Serizawa, et al.The Japanese Journal of Antibiotics|March 6, 2007
[Prophylactic effect of fosfomycin on postoperative infection in gastroenterological surgery]Nagao Shinagawa, Isamu Mizuno, Takuji Fukui, et al.Clinical Lung Cancer|January 7, 2017
Comparison of Clinically Relevant Mutation Profiles Between Preoperative Biopsy and Corresponding Surgically Resected Specimens in Japanese Patients With Non-Small-cell Lung Cancer by Amplicon-based Massively Parallel SequencingMitsuhiro Isaka, Masakuni Serizawa, Hirotsugu Kenmotsu, et al.Cancer Reports (Hoboken, N.J.)|September 9, 2024
Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung CancerMeiko Morita, Akira Ono, Motoki Sekikawa, et al.Scientific Reports|October 26, 2022
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genesSumiko Ohnami, Akane Naruoka, Mitsuhiro Isaka, et al.Cancer Medicine|May 14, 2020
Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole-slide imagesAkira Ono, Yukihiro Terada, Takuya Kawata, et al.Pageof 14